SOPHERION THERAPEUTICS INC has a total of 17 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are TISDALE MICHAEL JOHN, ARPI MATOSSIAN ROGERS and AEGERION PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 3 | |
#4 | United States | 3 | |
#5 | Australia | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Landin Judith | 9 |
#2 | Corso Melissa | 9 |
#3 | Rastelli Luca | 9 |
#4 | Kitson Richard | 6 |
#5 | Souan Lina | 5 |
#6 | Malyankar Uriel M | 5 |
#7 | Ashkar Samy | 5 |
#8 | Lescoe Mary K | 4 |
#9 | Malyankar Uriel | 4 |
#10 | Brunson Kenneth | 4 |
Publication | Filing date | Title |
---|---|---|
WO2010118265A1 | Non-pegylated liposomal doxorubicin triple combination therapy | |
EP1812030A2 | Anti-angiogenic peptides and methods of use thereof | |
AU2005267734A1 | Anti-angiogenic peptides and methods of use thereof | |
AU2003237456A1 | Method to screen ligands using eukaryotic cell display | |
EP1912069A2 | Method to screen ligands using eukaryotic cell display |